170 related articles for article (PubMed ID: 30713793)
21. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
Hirschowitz EA; Crystal RG
Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
[TBL] [Abstract][Full Text] [Related]
22. Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.
Huuhtanen J; Kasanen H; Peltola K; Lönnberg T; Glumoff V; Brück O; Dufva O; Peltonen K; Vikkula J; Jokinen E; Ilander M; Lee MH; Mäkelä S; Nyakas M; Li B; Hernberg M; Bono P; Lähdesmäki H; Kreutzman A; Mustjoki S
J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36719749
[TBL] [Abstract][Full Text] [Related]
23. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
Markel G; Lieberman N; Katz G; Arnon TI; Lotem M; Drize O; Blumberg RS; Bar-Haim E; Mader R; Eisenbach L; Mandelboim O
J Immunol; 2002 Mar; 168(6):2803-10. PubMed ID: 11884449
[TBL] [Abstract][Full Text] [Related]
24. Shaping of CD56
Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2019; 10():547. PubMed ID: 30949182
[TBL] [Abstract][Full Text] [Related]
25. Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.
Terunuma H
J Stem Cells Regen Med; 2012; 8(3):205-6. PubMed ID: 24693200
[TBL] [Abstract][Full Text] [Related]
26. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
Ma D; Niederkorn JY
Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.
Messaoudene M; Périer A; Fregni G; Neves E; Zitvogel L; Cremer I; Chanal J; Sastre-Garau X; Deschamps L; Marinho E; Larousserie F; Maubec E; Avril MF; Caignard A
PLoS One; 2015; 10(7):e0133363. PubMed ID: 26218530
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
30. Soluble branched (1,4)-beta-D-glucans from Acetobacter species enhance antitumor activities against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response.
Kamiryo Y; Yajima T; Saito K; Nishimura H; Fushimi T; Ohshima Y; Tsukamoto Y; Naito S; Yoshikai Y
Int J Cancer; 2005 Jul; 115(5):769-76. PubMed ID: 15729692
[TBL] [Abstract][Full Text] [Related]
31. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
[No Abstract] [Full Text] [Related]
32. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
33. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
[TBL] [Abstract][Full Text] [Related]
34. Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A.
Jiang YZ; Couriel D; Mavroudis DA; Lewalle P; Malkovska V; Hensel NF; Dermime S; Molldrem J; Barrett AJ
Immunology; 1996 Mar; 87(3):481-6. PubMed ID: 8778037
[TBL] [Abstract][Full Text] [Related]
35. IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors.
Seo H; Kim BS; Bae EA; Min BS; Han YD; Shin SJ; Kang CY
Cancer Immunol Res; 2018 Jun; 6(6):685-695. PubMed ID: 29615398
[TBL] [Abstract][Full Text] [Related]
36. Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.
Messaoudene M; Fregni G; Fourmentraux-Neves E; Chanal J; Maubec E; Mazouz-Dorval S; Couturaud B; Girod A; Sastre-Garau X; Albert S; Guédon C; Deschamps L; Mitilian D; Cremer I; Jacquelot N; Rusakiewicz S; Zitvogel L; Avril MF; Caignard A
Cancer Res; 2014 Jan; 74(1):81-92. PubMed ID: 24225017
[TBL] [Abstract][Full Text] [Related]
37. Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues.
Andalib AR; Lawry J; Ali SA; Murray AK; Sisley K; Silcocks P; Herlyn M; Rees RC
Melanoma Res; 1997 Feb; 7(1):32-42. PubMed ID: 9067963
[TBL] [Abstract][Full Text] [Related]
38. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
39. FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma.
Tan AC; Emmett L; Lo S; Liu V; Kapoor R; Carlino MS; Guminski AD; Long GV; Menzies AM
Ann Oncol; 2018 Oct; 29(10):2115-2120. PubMed ID: 30137228
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.
Jones NM; Yang H; Zhang Q; Morales-Tirado VM; Grossniklaus HE
BMC Cancer; 2019 May; 19(1):484. PubMed ID: 31117965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
